Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Feb 09, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000058.pdf 0001968202-24-000058.xls
Feb 09, 2024	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001422848-24-000245.pdf 0001422848-24-000245.xls
Feb 08, 2024	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001104659-24-012275.pdf 0001104659-24-012275.xls
Feb 08, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000056.pdf 0001968202-24-000056.xls
Feb 08, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-24-000766.pdf
Feb 08, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001973141-24-000090.pdf 0001973141-24-000090.xls
Feb 07, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001969223-24-000045.pdf
Feb 07, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001969223-24-000047.pdf
Feb 07, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001969223-24-000050.pdf 0001969223-24-000050.xls
Feb 06, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000053.pdf 0001968202-24-000053.xls

Data provided by Kaleidoscope.

Investors & Media